| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 07/24/2001 | US6265557 Nucleotide sequences associated with serology; for use in organ transplantion |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6263745 Flow cytometer nozzle and flow cytometer sample handling methods |
| 07/19/2001 | WO2001051672A2 System and method for controlling male fertility |
| 07/19/2001 | WO2001051666A1 Methods for diagnosing and treating heart disease |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051612A1 Process for the production of non-human embryos of high-genetic value and of predetermined sex |
| 07/19/2001 | WO2001051607A1 Quantification of cellular injury using expression of a fluorescent protein under the control of the gadd153 promoter |
| 07/19/2001 | WO2001051604A2 Methods for identifying anti-cancer drug targets |
| 07/19/2001 | WO2001050883A2 Rearing of aquatic species with dha-rich prey organisms |
| 07/19/2001 | WO2001050880A2 Cultivation of dha-rich prey organisms for aquatic species |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001050846A1 Intra-vascular administration of particles to induce pulmonary hypertension, pulmonary hypertension syndrome, and ascites in animals |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2396330A1 Methods for diagnosing and treating heart disease |
| 07/19/2001 | CA2396311A1 Methods for identifying anti-cancer drug targets |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/18/2001 | EP1116790A1 Murine models characterized by conditional mutation of SMN gene - use for study of spinal muscular atrophy and other neurodegenerative diseases and muscular myopathies |
| 07/18/2001 | EP1115861A2 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation |
| 07/18/2001 | EP1115857A1 Use of specific hybrid promoters for controlling tissue expression |
| 07/18/2001 | EP1115853A2 Analysis of ligand activated nuclear receptors in vivo |
| 07/18/2001 | EP1115851A1 Method of screening for large offspring syndrome |
| 07/18/2001 | EP0578653B1 Gene construct for production of transgenic fish |
| 07/18/2001 | CN1304454A Novel nucleic acids and polypeptides related to farnesyl-directed endopeptidase |
| 07/18/2001 | CN1304446A Poly (ADP-ribose) polymerse gene |
| 07/18/2001 | CN1304445A Method for producing cloned tigers by employing inter-species nuclear transplantation technique |
| 07/18/2001 | CN1304444A Method for producing human cloned embryos by employing inter-species nuclear transplantation technique |
| 07/18/2001 | CN1304443A Method for producing clened cows |
| 07/18/2001 | CN1303592A Xinglong meat dog raising method |
| 07/18/2001 | CN1303591A High-effective multilayer breeding farm |
| 07/18/2001 | CN1303590A Snake raising method |
| 07/18/2001 | CN1303589A Soft-shelled turtle raising method |
| 07/18/2001 | CN1068498C Artificial supplement feed for silkworms and raising method |
| 07/17/2001 | US6262337 Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B DNA) and uses thereof |
| 07/17/2001 | US6262336 Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter |
| 07/17/2001 | US6262335 Transgenic mice expressing APP mutant at amino acids 717, 721 and 722 |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262242 Tumor suppressor designated TS10Q23.3 |
| 07/17/2001 | US6261791 Method for diagnosing cancer using specific PSCA antibodies |
| 07/17/2001 | US6261786 Determining compounds that inhibit binding of polypeptides to naturally occuring patched receptor by mixing a vertebrate polypeptide with a patched receptor and a test compound; measure binding ability |
| 07/12/2001 | WO2001049856A2 Drosophila enzymes, encoding nucleic acids and methods of use |
| 07/12/2001 | WO2001049844A1 Compositions and methods for gene silencing |
| 07/12/2001 | WO2001049112A2 Oocyte vitrification technique |
| 07/12/2001 | WO2001049106A2 Method for cloning animals with targetted genetic alterations |
| 07/12/2001 | WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 07/12/2001 | WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010008026 System for tissue-restricted gene recombination |
| 07/12/2001 | US20010008025 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 07/12/2001 | US20010007768 Colorimetric analysis |
| 07/12/2001 | CA2396219A1 Oocyte vitrification technique |
| 07/12/2001 | CA2396210A1 Method for cloning animals with targetted genetic alterations by transfer_of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells |
| 07/12/2001 | CA2329318A1 Transgenic animal model of basal cell carcinoma |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
| 07/11/2001 | CN2438330Y Silkworm cocoon production apparatus |
| 07/11/2001 | CN1303429A Therapeutic applications of mature FLINT (mFLINT) polypeptides or OPG3, member of TNF receptor superfamily |
| 07/11/2001 | CN1302901A Method for reproducing fly maggot with transgenic antibacterial peptide |
| 07/10/2001 | US6258998 Method of cloning porcine animals |
| 07/10/2001 | US6258937 Hepadnavirus receptor |
| 07/10/2001 | US6258557 Nucleotide sequences associated with preferential gene expression; for the treatment of vascular injury; for reducing or preventing the development of arteriosclerosis |
| 07/05/2001 | WO2001048483A2 Method for screening of appetite control agents |
| 07/05/2001 | WO2001048240A2 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 07/05/2001 | WO2001048224A1 Repressible sterility of animals |
| 07/05/2001 | WO2001048163A2 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | WO2001048162A2 Method for the production of vitamin a |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001047354A1 Model animal with favorite onset of rheumatoid arthritis |
| 07/05/2001 | WO2001047353A1 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
| 07/05/2001 | WO2001012777A3 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 07/05/2001 | WO2001011018A3 Avian blastodermal cell lines |
| 07/05/2001 | WO2001002019A3 Control of gene expression |
| 07/05/2001 | WO2001000822A3 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 07/05/2001 | WO2000024246A9 Transgenic fish carrying plasmid for mutation detection and methods |
| 07/05/2001 | WO2000017334A9 Analysis of ligand activated nuclear receptors i(in vivo) |
| 07/05/2001 | US20010007153 Solid chimeric organs, animal models having same, process for preparing same, non-tumorigenic immortalized human cell lines, susceptible cells and cytopathic mammalian viruses |
| 07/05/2001 | US20010006948 So the gene is expressed; producing animal models for degenerative disc disease; genetically modified intervertebral disc cells; gene therapy |
| 07/05/2001 | US20010006630 Biological material such as cell, and purified extracellular matrix degrading enzyme externally adhered thereto; for treating mucopolysaccharidoses, cystic fibrosis, parkinson's disease, Gaucher's syndrome and osteogeneis imperfecta |
| 07/05/2001 | CA2395535A1 Method for the production of vitamin a |
| 07/05/2001 | CA2395490A1 Repressible sterility of animals |
| 07/05/2001 | CA2395439A1 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395003A1 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/04/2001 | EP1113081A1 Implication of a known gene named CP2/LSF/LBP-1 in Alzheimer's disease |
| 07/04/2001 | EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112353A2 Recombinant protein production in urine |
| 07/04/2001 | EP1112083A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 07/04/2001 | EP1111991A1 Method of performing transgenesis |
| 07/04/2001 | EP1007628A4 Transgenic model for heart failure |
| 07/04/2001 | EP0851766A4 Method for analyzing the immunosuppressant activity of ion channel blockers using the mini-pig |
| 07/04/2001 | CN1302376A Corticotropin releasing factor receptor-1 deficient mice |
| 07/04/2001 | CN1302335A Method for ballistic transformation of caenorhabditis elegant |